Buy AZZALURE®
Showing the single result
-


AZZALURE® 2 vials
$ 349.00 Read More-+AZZALURE® is the aesthetic brand name for abobotulinumtoxinA, manufactured by Ipsen and marketed by Galderma across the EU and UK. It carries CE marking, is supplied as 125U lyophilized vials in a 2-vial pack, and is indicated for the treatment of moderate to severe glabellar lines in adults. For practitioners looking to buy AZZALURE® or explore sourcing options, Direct Doctor Supply representatives are available to provide guidance on availability and purchasing requirements.
What Is AZZALURE®? Galderma’s Aesthetic AbobotulinumtoxinA Explained
AZZALURE® is a botulinum toxin type A product, specifically abobotulinumtoxinA, manufactured by Ipsen and distributed under the Galderma name for the EU and UK aesthetic market. Like other products in its class, it functions as a muscle relaxant by blocking the release of acetylcholine at the neuromuscular junction, which prevents the targeted muscle from contracting. Its mechanism of action is straightforward: less muscle movement in the treated area means the overlying skin creases less, and this is the basis for treating dynamic wrinkles and fine lines and wrinkles associated with repeated facial expression.
A few defining facts about AZZALURE® as an aesthetic treatment:
- It is CE-marked, meaning it meets EU regulatory standards for pharmaceuticals sold in the European Economic Area and the UK.
- It is supplied only as a 125U lyophilized (freeze-dried) powder that requires reconstitution before injection [4].
- Its primary licensed indication is moderate to severe glabellar lines (the vertical lines between the eyebrows, sometimes called frown lines) [4].
- It shares its active substance with DYSPORT®, though the two are positioned for different markets.
AZZALURE® 125U — Product Presentation and Vial Format
AZZALURE® comes in a single presentation: a 125U vial of lyophilized powder, typically supplied as an Azzalure 125 IU 2-vial pack [4]. There is no range of vial sizes to choose from, unlike some competitor brands that offer multiple unit counts per box. This keeps ordering and stock management relatively simple, but it also means practitioners need to plan dosing and reconstitution volumes carefully, since the full product range consists of this one format.
How to Reconstitute AZZALURE® — Preparation Protocol
Reconstitution is a standard step in preparing AZZALURE® for injection, and the correct injection technique starts with getting the dilution right.
- Standard dilution: Add 1.25 mL of sterile saline to the 125U vial. This yields a concentration of 10U per 0.1 mL [4].
- Alternative dilution: Some practitioners use 2.5 mL of sterile saline instead, yielding 5U per 0.1 mL [4]. The choice between these depends on practitioner preference and treatment plan.
After adding saline, rotate the vial gently to mix. Do not shake it, as this can damage the toxin’s protein structure. The reconstituted solution should look clear and colorless. Do not use anything cloudy or discolored.
When AZZALURE® is injected into the skin, the precision of the dilution step directly affects the dose delivered per injection point. On the question of how long AZZALURE® can be out of the fridge, there are two separate answers depending on the product’s state:
- Unopened vials: Manufacturer guidance allows storage at or below 25°C for up to 3 months within the overall shelf life, but this can vary by batch and country, so it is worth checking the current instructions for use (IFU) rather than relying on a blanket rule.
- Reconstituted product: Once mixed, it should be used within 24 hours and kept refrigerated in the meantime.
Is AZZALURE® the Same as DYSPORT®? Understanding the Relationship
AZZALURE® and DYSPORT® contain the exact same active substance, abobotulinumtoxinA, and come from the same manufacturer, Galderma/Ipsen. What differs is branding and market licensing, not the molecule itself.
- DYSPORT® is the global brand name, FDA-approved in the US, and licensed for a broader set of indications in various markets.
- AZZALURE® is the EU/UK-specific brand, licensed only for aesthetic use, with glabellar lines as its primary indication [4].
In terms of what is actually in the vial, they are the same product under different labels depending on where it is sold. This matters practically because the two use the same Speywood (Galderma) unit system, so no dose conversion is needed when switching between AZZALURE® and DYSPORT® for a similar indication.
Where things get more complicated is when comparing either of these to BOTOX®. Galderma/Speywood units are not equivalent to BOTOX® units. The commonly cited conversion is roughly 2.5 to 3 Galderma units per 1 BOTOX® unit for treating glabellar lines, though the exact ratio remains a point of debate in the published literature [2].
This is a critical distinction for anyone moving between product families, since dosing on a 1:1 basis across different toxin brands can lead to under- or overtreatment.
Treatment Areas and Clinical Indications
AZZALURE®’s CE-marked indication is specific: moderate to severe glabellar lines in adults under 65 [4]. Dynamic wrinkles are often caused by repeated facial muscle contractions over time, and when AZZALURE® is injected, it relaxes the underlying muscles, helping reduce the appearance of wrinkles on the skin’s surface.
Beyond its licensed use, practitioners sometimes apply AZZALURE® off-label to other areas, including:
- Forehead wrinkles
- Crow’s feet around the eyes
- Eyebrows and lips, for shaping or subtle lifting effects
- Neck bands
- Skin depressions in select areas [3]
Severe underarm sweating (hyperhidrosis) is treated with botulinum toxin in some markets, though this indication is more commonly associated with DYSPORT® than with AZZALURE® specifically. Since indications can vary by country and product license, it is worth confirming the current market-specific approval before treating hyperhidrosis with AZZALURE®.
Regulatory Status
AZZALURE® carries CE marking for aesthetic use in the European Union and the UK, where it is used to treat moderate to severe glabellar lines in adults younger than 65 years [4]. The product does not have FDA approval because Ipsen and Galderma market the same botulinum toxin formulation in the United States under the DYSPORT® brand.
AZZALURE® is a prescription-only medicine. Those looking to order AZZALURE® online or learn more about purchasing requirements can reach out to Direct Doctor Supply representatives for further guidance.
AZZALURE® Compared to Other Botulinum Toxin Brands
AZZALURE® vs BOTOX®
Although AZZALURE® and BOTOX® are both botulinum toxin type A products, they are not the same. AZZALURE® contains abobotulinumtoxinA, while BOTOX® contains onabotulinumtoxinA (AbbVie). One of the most important differences is that their dosing units are not interchangeable. For glabellar lines, published guidance commonly cites a conversion of approximately 2.5 to 3 units of AZZALURE® (or DYSPORT®) per 1 unit of BOTOX®, although the exact ratio remains a topic of discussion in the clinical literature [2].
AZZALURE® is approved for aesthetic use in CE-marked markets such as Europe and the UK, whereas BOTOX® has both FDA approval and CE marking across a much broader range of aesthetic and therapeutic indications.
In terms of onset, AZZALURE® may begin working within 2 to 5 days, while BOTOX® typically takes 3 to 7 days. Some clinicians report a slightly faster onset with AZZALURE®, but research has not consistently shown a meaningful difference between the two. BOTOX® has one of the longest and most extensively documented clinical histories among botulinum toxin products.
AZZALURE® vs NABOTA®
AZZALURE® and NABOTA® differ in formulation, manufacturer, and regulatory history. AZZALURE® contains abobotulinumtoxinA (Ipsen/Galderma, France), while NABOTA® contains prabotulinumtoxinA (Daewoong Pharmaceutical, South Korea). NABOTA® gained FDA approval in the United States as Jeuveau® (Evolus) in 2019 for glabellar lines, whereas AZZALURE® has a longer EU/UK clinical track record but is not FDA-approved.
NABOTA® is generally comparable to BOTOX® on a 1:1 unit basis, while AZZALURE® uses approximately 2.5 to 3 Galderma units for every 1 BOTOX® unit [2]. Both require refrigeration and are CE-marked in overlapping markets.
AZZALURE® vs DYSPORT®
This is the closest comparison of the set since both products contain the same active substance, abobotulinumtoxinA, from the same manufacturer. The difference is licensing: DYSPORT® is FDA-approved and sold across multiple markets, while AZZALURE® is the EU/UK aesthetic-only version, approved for moderate to severe glabellar lines.
Both use the same Speywood (Galderma) unit, so AZZALURE® 125U is roughly equivalent to DYSPORT® 125U, and no dose recalculation is needed when switching between them. The unit conversion concern arises only when moving to or from BOTOX®, where the Galderma-to-BOTOX® unit ratio (approximately 2.5:1 to 3:1) needs to be carefully accounted for [2].
AZZALURE® vs XEOMIN®
XEOMIN® and BOCOUTURE® are the same molecule, incobotulinumtoxinA, manufactured by Merz, but marketed under different names depending on the region. XEOMIN® is the internationally available, FDA-approved version, while BOCOUTURE® is the EU/UK aesthetic brand.
Comparing AZZALURE® (abobotulinumtoxinA) to XEOMIN® (incobotulinumtoxinA) involves structural differences, including different complexing protein profiles. XEOMIN® is generally treated as equivalent to BOTOX® units on a 1:1 basis, whereas AZZALURE® uses its own Galderma unit system [2]. Both are CE-marked. XEOMIN® can be stored at room temperature, which is a logistical advantage over AZZALURE®’s refrigeration requirement. There is no head-to-head randomized controlled trial directly comparing AZZALURE® vs other botulinum toxin products like XEOMIN® for efficacy, so most comparisons rely on indirect data.
AZZALURE® vs BOCOUTURE®
Both BOCOUTURE® and AZZALURE® are CE-marked for EU/UK aesthetic use and approved for glabellar lines. The main difference is composition. BOCOUTURE® (Merz) contains incobotulinumtoxinA, sometimes described as the “naked” toxin because it lacks the complexing proteins found in other formulations, which theoretically lowers the risk of immunogenicity with long-term use. AZZALURE® contains complexing proteins as part of its abobotulinumtoxinA formulation.
BOCOUTURE® is generally positioned as 1:1 with BOTOX® units, while AZZALURE® remains on the Galderma/Speywood system, which is not equivalent [2]. BOCOUTURE® also offers a room-temperature storage option, whereas AZZALURE® requires refrigeration throughout. Both remain prescription-only products.
Onset, Duration, and Clinical Performance
AZZALURE® usually starts working within 2 to 5 days, with full effect typically reached in 10 to 14 days [1]. Some clinicians have observed that Azzalure treatments work a little sooner than other botulinum toxin type A products in practice. However, clinical studies have not consistently confirmed this difference, so it should be viewed as a possibility rather than an expected outcome [3].
Most patients see results persisting for 3 to 4 months, with some extending to around 6 months depending on individual factors like dose, muscle mass, and metabolism [1]. When weighing if AZZALURE® is a good alternative to other botulinum toxins, the CE-marked clinical data for its glabellar line indication has been consistent, and the product remains widely used across EU and UK aesthetic practices specifically because those treatment outcomes tend to hold up over repeated sessions.
Storage and Shelf Life
- Unopened vials: AZZALURE® should normally be stored in the refrigerator at 2°C to 8°C. Some product information also allows unopened vials to be stored at 25°C or below for up to 3 months, provided they remain within the overall shelf life. Since storage recommendations can vary, always check the latest instructions for use before storing the product at room temperature.
- Reconstituted product: Use within 24 hours of mixing, and keep refrigerated during that window.
AZZALURE® requires cold-chain shipping, and vials should be inspected on arrival to confirm they have not been compromised in transit. Shipping conditions are particularly important for this product class, since temperature excursions during transport can affect stability.
AZZALURE® Price
AZZALURE® sits in the mid-to-premium range of the market, consistent with its position within the broader Galderma product portfolio. When comparing cost per treatment session against other botulinum toxin brands, it is important to factor in the Galderma unit-to-BOTOX® unit conversion [2]. A straight per-vial price comparison without adjusting for unit potency can be misleading.
For those looking to buy AZZALURE® wholesale, Direct Doctor Supply representatives can provide guidance on current pricing structures and available supply channels.
Clinical Benefits of AZZALURE®
AZZALURE® is a CE-marked Galderma product with a solid body of clinical evidence supporting its use for glabellar lines. Its diffusion profile, a known characteristic of abobotulinumtoxinA formulations, may offer an advantage when treating larger or broader areas such as the forehead, where even coverage across fine lines and wrinkles matters [3].
The 2-vial pack format supports bilateral treatment or multi-area sessions in a single visit. At Direct Doctor Supply, we have worked with practitioners who use AZZALURE® across multiple treatment areas in one session, and the 2-vial format tends to align well with that approach.
Side Effects and Safety
Common side effects associated with AZZALURE® tend to be mild and temporary [1]:
- Bruising at the injection site
- Headache
- Localized swelling
The most significant adverse event to watch for is ptosis (eyelid drooping), which remains the most commonly reported issue across upper-face BTX-A treatments generally, not just AZZALURE® specifically [3]. Brow asymmetry is another possibility if dosing or placement is not well calibrated. Side effects may include skin depressions in some cases.
More rarely, distant spread of the toxin beyond the injection site has been reported, which is a class-wide risk rather than something unique to AZZALURE®. Contraindications include neuromuscular disorders, pregnancy, and known hypersensitivity to botulinum toxin type A.
How to Buy AZZALURE® Online and Order AZZALURE® Wholesale
AZZALURE® is a prescription-only medicine, and sourcing it through authorized distribution channels is essential for licensed practitioners. Practitioners evaluating where to purchase AZZALURE® online should verify supplier credentials, including cold-chain compliance, certificate of analysis documentation, LOT number traceability, and verifiable purity documentation before accepting delivery.
Reviewing factors such as product sourcing, cold-chain handling, batch documentation, and shipping requirements helps support proper product storage, regulatory compliance, and informed purchasing decisions.
For those looking to order AZZALURE® online, Direct Doctor Supply representatives are happy to provide guidance on availability and sourcing. Practitioners who want to buy AZZALURE® wholesale or explore AZZALURE® products can contact the Direct Doctor Supply support team for detailed information on current supply options.
Frequently Asked Questions
What is AZZALURE®?
AZZALURE® is an abobotulinumtoxinA injectable manufactured by Galderma/Ipsen and CE-marked for the EU and the UK. It is approved for use in adults with moderate to severe glabellar lines and is supplied as 125U lyophilized 2-vial packs [4].
Is AZZALURE® the same as DYSPORT®?
AZZALURE® and DYSPORT® share the same active substance, abobotulinumtoxinA, and the same manufacturer, Galderma/Ipsen. The difference is branding: DYSPORT® is the global, FDA-approved product with broader indications, while AZZALURE® is the EU/UK aesthetic-only brand focused on glabellar lines.
What is AZZALURE® used for?
Its CE-marked indication is moderate to severe glabellar lines in adults under 65. It is also used off-label for forehead wrinkles, crow’s feet, eyebrows, and lips [3]. Severe underarm sweating is more commonly treated with DYSPORT® in some markets, so the indication should be confirmed per market for AZZALURE® specifically.
How is AZZALURE® reconstituted?
AZZALURE® is reconstituted by adding 1.25 mL of sterile 0.9% saline to a 125-unit vial, giving a concentration of 10 units per 0.1 mL [4]. Some practitioners prefer 2.5 mL of saline, yielding 5 units per 0.1 mL [4]. Mix the solution gently by rotating the vial instead of shaking it. Once reconstituted, store in the refrigerator and use within 24 hours.
How long does AZZALURE® take to work?
Onset typically occurs within 2 to 5 days, with full results at 10 to 14 days [1]. Some clinical reviews suggest slightly faster onset than other BTX-A products, though this has not been consistently confirmed in randomized trials.
How long does AZZALURE® last?
Most patients see effects lasting 3 to 4 months, with some reporting up to 6 months [1][4]. Duration varies based on dose, muscle mass, and individual metabolism.
How long can AZZALURE® be out of the fridge?
Unopened vials can generally be stored at temperatures of 25°C or below for up to 3 months, provided this remains within the product’s shelf life. It is always best to check the current instructions for use for storage recommendations based on country and batch. After reconstitution, AZZALURE® should be refrigerated and used within 24 hours.
Where can practitioners find information on buying AZZALURE®?
Direct Doctor Supply has been a trusted resource for verified licensed practitioners since 2014, offering guidance on product availability, verified supply, and sourcing documentation. For those looking to buy AZZALURE® or to purchase AZZALURE® online, the Direct Doctor Supply support team can provide up-to-date information on supply options and wholesale pricing.
All content on this website is intended for informational purposes and does not constitute medical advice.
References
- Rzany B, Ascher B, Monheit G. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol. 2010;24(s1):1-14. https://doi.org/10.1111/j.1468-3083.2009.03475.x
- Scaglione F. Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice. 2016;8(3):65. https://doi.org/10.3390/toxins8030065
- Ascher B, Talarico S, Cassuto D, et al. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part I: upper facial wrinkles. J Eur Acad Dermatol Venereol. 2010;24(11):1278-1284. https://doi.org/10.1111/j.1468-3083.2010.03631.x
- Galderma (U.K.) Limited. Azzalure, 125 Speywood units, powder for solution for injection – Summary of Product Characteristics (SmPC). Electronic Medicines Compendium (emc). Updated February 11, 2026. https://www.medicines.org.uk/emc/product/6584/smpc
Content prepared by Direct Doctor Supply’s editorial team.
Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.